Complete Up To Date Information about Antisedan .
NADA Number: 141-033 | |
| Proprietary Name |
Antisedan® |
|---|---|
| Sponsor |
Orion, Corp. |
| Sponsor Address |
Orionintie 1 Espoo, 02200 Finland |
| Ingredients |
Atipamezole Hydrochloride |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4689339 4933359 |
| Exclusivity |
No active ingredient has been previously approved in any other application. Additional indication (reversal of sedative and analgesic effects of Dexdomitor) |
|
Dosage Amount, Indications & Limitations |
522.147 Atipamezole hydrochloride. Specifications: Each milliliter of sterile injectable solution contains 5.0 milligrams of atipamezole hydrochloride. Conditions of use: Dogs Amount: Inject intramuscularly the same volume as that of dexmedetomidine or medetomidine used. Indications: For reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride or medetomidine hydrochloride. Limitations: For intramuscular use only. Not recommended for use in pregnant or lactating animals, or animals intended for breeding. Atipamezole has not been evaluated in breeding animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |